Is it always necessary to reverse the neuromuscular blockade at the end of surgery?
Christian Bohringer
Hong Liu
摘要:Neuromuscular blocking agents (NMBAs) were introduced into clinical anesthesia in the 1940s[1],and have enabled anesthesiologists to safely anesthetize patients with significant cardiopulmonary diseases.By employing neuromuscular blockade patient movement could be abolished,without producing excessive cardiovascular depression.The risks of employing neuromuscular blocking drugs,however,are the potential for intra-operative awareness and the persistence of the neuromuscular block into the post-operative period,especially with non-depolarizing NMBAs[2-3].
机标关键词:
分类号:R614.4(外科手术学)
论文发表日期:2019-01-01
在线出版日期:2025-08-15(本平台首次上网日期,不代表文献的发表时间)
页数:4( 217-220 )
生物医学研究杂志(英文版)

生物医学研究杂志(英文版)

ISSN:1674-8301
年,卷(期):2019,33(4)
所属栏目:PERSPECTIVE